NO964284D0 - Fusogene liposomer og fremgangsmåter for fremstilling og anvendelse derav - Google Patents

Fusogene liposomer og fremgangsmåter for fremstilling og anvendelse derav

Info

Publication number
NO964284D0
NO964284D0 NO964284A NO964284A NO964284D0 NO 964284 D0 NO964284 D0 NO 964284D0 NO 964284 A NO964284 A NO 964284A NO 964284 A NO964284 A NO 964284A NO 964284 D0 NO964284 D0 NO 964284D0
Authority
NO
Norway
Prior art keywords
lipid
outermost
lipid bilayer
liposome
bilayer
Prior art date
Application number
NO964284A
Other languages
English (en)
Other versions
NO964284L (no
NO318814B1 (no
Inventor
Austin Bailey
Pieter R Cullis
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO964284D0 publication Critical patent/NO964284D0/no
Publication of NO964284L publication Critical patent/NO964284L/no
Publication of NO318814B1 publication Critical patent/NO318814B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO19964284A 1994-04-12 1996-10-09 Liposomsammensetninger, dehydrerte unilamellaere liposomer og fremgangsmater derav. NO318814B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003996 WO1995027478A1 (en) 1994-04-12 1994-04-12 Fusogenic liposomes and methods of making and using same

Publications (3)

Publication Number Publication Date
NO964284D0 true NO964284D0 (no) 1996-10-09
NO964284L NO964284L (no) 1996-10-09
NO318814B1 NO318814B1 (no) 2005-05-09

Family

ID=22242444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964284A NO318814B1 (no) 1994-04-12 1996-10-09 Liposomsammensetninger, dehydrerte unilamellaere liposomer og fremgangsmater derav.

Country Status (13)

Country Link
EP (1) EP0758883B1 (no)
JP (1) JP3804025B2 (no)
KR (1) KR100315132B1 (no)
AT (1) ATE234605T1 (no)
AU (1) AU689479B2 (no)
CA (1) CA2187748C (no)
DE (1) DE69432320T2 (no)
DK (1) DK0758883T3 (no)
ES (1) ES2196028T3 (no)
FI (1) FI964083A0 (no)
NO (1) NO318814B1 (no)
NZ (1) NZ268146A (no)
WO (1) WO1995027478A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339069B1 (en) 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
US6087325A (en) * 1996-10-15 2000-07-11 The Liposome Company, Inc. Peptide-lipid conjugates
JP4656675B2 (ja) 1997-05-14 2011-03-23 ユニバーシティー オブ ブリティッシュ コロンビア 脂質小胞への荷電した治療剤の高率封入
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
MXPA02002107A (es) * 1999-08-27 2003-08-20 Inex Pharmaceuticals Corp Composiciones para estimular la secrecion de citoquina e inducir una respuesta inmune.
EP1613285A2 (en) * 2003-03-31 2006-01-11 Alza Corporation Lipid particles having asymmetric lipid coating and method of preparing same
JP4787818B2 (ja) * 2005-01-28 2011-10-05 独立行政法人科学技術振興機構 脱水縮合反応により相転移を生じ得る分子集合体およびその相転移方法
EP3494964B1 (en) * 2007-05-14 2021-04-07 Konica Minolta Holdings, Inc. Liposome and method for producing liposome
WO2011017297A2 (en) 2009-08-03 2011-02-10 The University Of North Carolina At Chapel Hill Biodegradable delivery system complexes for the delivery of bioactive compounds
EP3403647A1 (en) 2009-12-01 2018-11-21 Translate Bio, Inc. Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
EP2717893B1 (en) 2011-06-08 2019-05-08 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mrna delivery
US20150267192A1 (en) 2012-06-08 2015-09-24 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
AU2014236396A1 (en) 2013-03-14 2015-08-13 Shire Human Genetic Therapies, Inc. Methods for purification of messenger RNA
CN105142676B (zh) 2013-03-14 2022-06-28 夏尔人类遗传性治疗公司 Cftr mrna组合物以及相关方法和用途
JP6506749B2 (ja) 2013-10-22 2019-04-24 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド フェニルケトン尿症のためのｍＲＮＡ療法
MX2016005237A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Terapia de acido ribonucleico mensajero para la deficiencia de argininosuccinato sintetasa.
PT3134506T (pt) 2014-04-25 2019-10-31 Translate Bio Inc Métodos de purificação de rna mensageiro
US11253605B2 (en) 2017-02-27 2022-02-22 Translate Bio, Inc. Codon-optimized CFTR MRNA
US11173190B2 (en) 2017-05-16 2021-11-16 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
WO2020041793A1 (en) 2018-08-24 2020-02-27 Translate Bio, Inc. Methods for purification of messenger rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JP2760355B2 (ja) * 1986-06-16 1998-05-28 ザ リポソーム カンパニー，インコーポレイテッド 不均整誘導リポソーム
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells

Also Published As

Publication number Publication date
DE69432320D1 (de) 2003-04-24
CA2187748C (en) 2007-04-10
ES2196028T3 (es) 2003-12-16
EP0758883A1 (en) 1997-02-26
JPH09511521A (ja) 1997-11-18
NZ268146A (en) 1997-10-24
ATE234605T1 (de) 2003-04-15
AU7091594A (en) 1995-10-30
NO964284L (no) 1996-10-09
JP3804025B2 (ja) 2006-08-02
EP0758883B1 (en) 2003-03-19
FI964083A (fi) 1996-10-11
DE69432320T2 (de) 2003-12-04
NO318814B1 (no) 2005-05-09
DK0758883T3 (da) 2003-06-02
CA2187748A1 (en) 1995-10-19
AU689479B2 (en) 1998-04-02
FI964083A0 (fi) 1996-10-11
WO1995027478A1 (en) 1995-10-19
KR100315132B1 (ko) 2002-06-26

Similar Documents

Publication Publication Date Title
NO964284L (no) Fusogene liposomer og fremgangsmåter for fremstilling og anvendelse derav
EP0607118A4 (en) ADMINISTRATION SYSTEM FOR PHOSPHOLIPID.
AU1724097A (en) Lipids and their use, for example, in liposomes
DE69505677D1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
AU4711296A (en) Method for loading lipid vesicles
DE69425901D1 (de) Vesikel mit gesteuerter wirkstofffreisetzung
ATE286718T1 (de) Temperatursensitive liposomale formulierung
EP0171710A3 (en) Process for preparing liposome composition
AU8141791A (en) Method for determining unentrapped ionizable bioactive agents in liposome preparations
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
DK0592446T3 (da) Fyldningsteknik til fremstilling af lægemiddelholdige liposomer
AU7343894A (en) Biphasic multilamellar lipid vesicles
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
AU2520595A (en) Virosome-mediated intracellular delivery of therapeutic agents
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
KR920002165A (ko) 리포좀 생성물
WO1999021533A3 (en) Delivery vehicles for bioactive agents and uses thereof
AR002735A1 (es) Formulaciones liquidas de sustancias insecticidas activas.
Fujisawa et al. Action of drugs on liposomes with varying charges
Kusaka et al. Characterization of glutamate transport system in hydrophobic protein (H protein) of Bacillus subtilis
IONOPHORE et al. Laboratory of Experimental Medicine, Brussels University, Brussels, B-1000 (Belgium)
HUP9903412A3 (en) Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
WO2002058627A3 (en) A cystic fibrosis transmembrane-conductance regulator (cftr)-membrane translocation sequence fusion protein (cftr-mts) as a therapeutic agent